Fondazione Pezcoller

E tu, come avresti reagito? L’𝗲𝘀𝗽𝗲𝗿𝗶𝗺𝗲𝗻𝘁𝗼 𝘀𝗼𝗰𝗶𝗮𝗹𝗲 che ha commosso i visitatori di una mostra d’arte 🎨 Guarda fino alla fine, rimarrai sorpreso. Un collettivo di ricercatori ha organizzato tutto questo per vedere la 𝘳𝘦𝘢𝘻𝘪𝘰𝘯𝘦 delle persone e sensibilizzarle sulla delicata tematica della ricerca oncologica 🔬 È solo grazie alla ricerca se sempre più ricercatori, con attrezzatura sempre più performante, riescono a riconoscere e a diagnosticare in tempo la malattia. La ricerca di oggi è la cura di domani, per tutti! ❣️ Scopri come donare su https://lnkd.in/dJfP4hNs E condividi il video per diffondere il messaggio 📣 #UnNuovoDomani #FondazionePezcoller

We're taking a break: see you on 7th January. Happy holiday to everyone! ✨🎄

Thanks to donations, many researchers around the world continue their cancer studies and develop new therapies. Read the interview with Isidro Cortés-Ciriano, winner of the 2023 Rising Star Award: https://lnkd.in/dZDFrBBq And contribute to research: 𝗗𝗢𝗡𝗔𝗧𝗘 𝗡𝗢𝗪! https://lnkd.in/duhYNWKy 👩🔬❤️

Last Tuesday we hosted with great pleasure the Prof. Elisa Oricchio, winner of the Pezcoller Award - European Association for Cancer Research (EACR) Translational Cancer Researcher Award 2024! 🏅 This award recognizes researchers who done outstanding work in basic cancer research, and who have also demonstrated the potential future clinical development of their studies. 👉🏻 Great success for the lecture of prof. Oricchio at UniTrento CIBIO in which she showed her work with his lab team in Lausanne. 🔬 Prof. Oricchio has developed an innovative method to find the right therapy for various types of cancer. She took “tumor fragments” from cancer patients and tested different treatments on them. In this way, she was able to analyze the reactions of cancer cells, and figure out the best therapeutic strategy. ▶️ Discover more here: https://lnkd.in/dnzvvvF8

𝐂𝐇𝐈𝐀𝐑𝐀 𝐃𝐄 𝐒𝐀𝐍𝐓𝐈 is the recipient of the 2024/2025 Pezcoller fellowship for the Master of Science Communication “Franco Prattico” at SISSA (Trieste)! 🥳🎉 🎓 Dr. De Santi has a Postgraduate Degree in Chemistry (University of Padua) and she is specialized in Nuclear Magnetic Resonance spectroscopy. She worked for several years in a pharmaceutical research company, she is always been interested in science and actively participated in various initiatives, as a volunteer. 🍀 𝑪𝒐𝒏𝒈𝒓𝒂𝒕𝒖𝒍𝒂𝒕𝒊𝒐𝒏𝒔 𝒕𝒐 𝑫𝒓. 𝑫𝒆 𝑺𝒂𝒏𝒕𝒊 𝑎𝑛𝑑 𝑏𝑒𝑠𝑡 𝑤𝑖𝑠ℎ𝑒𝑠 𝑓𝑜𝑟 𝑤𝑜𝑟𝑘 𝑓𝑟𝑜𝑚 𝑡ℎ𝑒 𝑃𝑒𝑧𝑐𝑜𝑙𝑙𝑒𝑟 𝐹𝑜𝑢𝑛𝑑𝑎𝑡𝑖𝑜𝑛!   Discover more here 👉 https://lnkd.in/d53hTZQe

𝗖𝗿𝗲𝗮𝗿𝗲 𝘁𝗲𝗿𝗮𝗽𝗶𝗲 𝗽𝗲𝗿𝘀𝗼𝗻𝗮𝗹𝗶𝘇𝘇𝗮𝘁𝗲 𝘀𝘂𝗹𝗹𝗮 𝗯𝗮𝘀𝗲 𝗱𝗲𝗹 𝘁𝗶𝗽𝗼 𝗱𝗶 𝗰𝗮𝗻𝗰𝗿𝗼 𝗰𝗵𝗲 𝗵𝗮 𝗶𝗹 𝗽𝗮𝘇𝗶𝗲𝗻𝘁𝗲? 𝗢𝗴𝗴𝗶 𝗲̀ 𝗽𝗼𝘀𝘀𝗶𝗯𝗶𝗹𝗲. La vincitrice del Translational Cancer Researcher 2024, Elisa Oricchio, con il suo team e in collaborazione con alcuni ospedali della Svizzera francese, sviluppa modelli predittivi che siano in grado di aiutare pazienti affetti da tumore. Leggi l'intervista uscita ieri su Il T Quotidiano 👉 https://lnkd.in/dwAz4wDE

It's a pleasure to host in Trento Professor Elisa Oricchio, from EPFL and Director of the Swiss Institute for Experimental Cancer Research (ISREC), winner of 2024 The Pezcoller Foundation - European Association for Cancer Research (EACR) Translational Cancer Researcher Award 🌟 She'll hold a scientific lecture at UniTrento CIBIO titled "Integrate multiple dimensions to understand tumor evolution and design new therapies" about her research. She identified oncogenes or tumor suppressor genes as new therapeutic targets or as biomarkers to better classify cancer patients, also integrating linear cancer genomic analyses with tridimensional genome analyses to better understand tumor development and evolution. ⏰ Tuesday 26 November, at 4:30 PM 📍 Sala Stringa FBK - via Sommarive 18, Povo (TN) 👉🏻 https://lnkd.in/dnzvvvF8

The 2025 winner of the Fondazione PezcollerTranslational Cancer Researcher Award is Ido Amit 👏 Prof. Amit will deliver his Award Lecture at #EACR2025! https://lnkd.in/eHrgVz59

🎉 Felicitaties aan Karin de Visser, die de prestigieuze 2025 Pezcoller-Marina Larcher Fogazzaro-EACR Women in Cancer Research Award wint! Deze internationale onderscheiding, uitgereikt door de European Association for Cancer Research (EACR) en de Fondazione Pezcoller, erkent baanbrekend kankeronderzoek door vrouwelijke wetenschappers en hun inzet voor vrouwen in de wetenschap. Karin de Visser, tumor-immunoloog en groepsleider bij The Netherlands Cancer Institute, hoogleraar aan het Leiden University Medical Center (LUMC) en groepsleider bij Oncode Institute heeft met haar team belangrijke ontdekkingen gedaan over hoe borstkanker het immuunsysteem ontwijkt en soms manipuleert. Deze baanbrekende inzichten dragen bij aan nieuwe immuuntherapieën die specifiek inspelen op het genetische profiel van de tumor. De Visser: “Met ons wetenschappelijk onderzoek hopen we bij te dragen aan de ontwikkeling van nieuwe vormen van immuuntherapie voor borstkanker, zodat er uiteindelijk meer patiënten van immuuntherapie zullen profiteren.” De award zal officieel worden uitgereikt tijdens het jaarlijkse EACR-congres in juni 2025 in Lissabon, waar De Visser ook een speciale lezing zal geven. 👏 Meer over deze bijzondere erkenning lees je op onze website ➡️ https://bit.ly/48Mivjy #immuuntherapie #kankeronderzoek #borstkanker #hetAVL #NKI #award

I am deeply honored and grateful to receive the 2025 Pezcoller-Marina Larcher Fogazzaro-EACR Women in Cancer Award. Thank you European Association for Cancer Research (EACR) and Fondazione Pezcoller. Cancer research is a team effort. Tremendous thanks to my amazing lab, the The Netherlands Cancer Institute , Oncode Institute , Leiden University Medical Center , colleagues and family!